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Congress, Illinois Think Canada Is Answer
to Prescription Drug Woes
Katherine Licup
An elderly woman cried
when she discovered a prescription
for tomoxifen, a drug she used to treat
breast cancer, cost $45 at the Rx
Depot in Tulsa, Oklahoma.'
She was not upset; she was
overjoyed.
Rx Depot owner Carl Moore
said that the same prescription at a
local pharmacy cost the woman $390.
The customer had stopped taking the
drug a year earlier because she could
not afford it.
Rx Depot is able to sell drugs
cheaper than other local pharmacies
because the medicine is reimported -
exported to Canada and then shipped
back to the United States. Moore has
opened 80-plus stores that cater to
people who cannot ordinarily afford
to pay for their prescriptions.
There is just one problem:
Moore's business is illegal. While the
United States currently allows indi-
viduals to get a 90-day supply of
medication from Canada, only phar-
maceutical companies are authorized
to reimport drugs. An Oklahoma state
court recently ordered Moore to cease
operating his stores in that state. The
Department of Justice is seeking to
halt his operations in 22 other states
in a federal trial beginning this fall.2
Americans who live in north-
ern states have long been aware that
the same drugs available in their local
pharmacies cost much less in Canada,
and have crossed the border to pur-
chase them. Now entrepreneurs like
Moore, as well as Congress and some
state governments, are seeking to
reimport drugs on a massive level.
According to the language in
the proposed Pharmaceutical Market
Access Act of 2003, Americans pay
up to 1,000% more for prescription
drugs than foreign consumers do. 3
The Congressional Budget Office pre-
dicts that in the next 10 years
American seniors will spend $1.8 tril-
lion on pharmaceuticals.
"While American com-
panies manufacture
most of the world's
drug supply, they sell
drugs abroad at a frac-
tion of the price
Americans pay....
Americans end up pay-
ing higher prices to
recoup the enormous
costs of pharmaceutical
research, development
and marketing."
"One quarter of senior citi-
zens have no prescription drug insur-
ance, and many seniors have only
limited coverage," said Rep. Rahm
Emanuel (D-Ill.), one of the bill's co-
sponsors. "A recent study showed that
about 30% of seniors do not fill at
least some of their prescriptions
because of cost."
While American companies
manufacture most of the world's drug
supply, they sell drugs abroad at a
fraction of the price Americans pay,
primarily due to foreign government
price controls. 4 Americans end up
paying higher prices to recoup the
enormous costs of pharmaceutical
research, development, and market-
ing.
The proposed federal legisla-
tion would authorize the Secretary of
Health and Human Services to insti-
tute regulations to allow reimporta-
tion of FDA-approved drugs, but with
protections in place to combat coun-
terfeit, unregulated, and dangerous
drugs.
State and local governments
are proposing similar measures.
Illinois Gov. Rod Blogojevich com-
missioned a study in September to
determine the feasibility of providing
reimported drugs to state employees
and retirees.5 He has even established
a Web site where people can sign a
petition calling for the legalization of
reimportation.6 Springfield,
Massachusetts, and the AARP have
initiated programs that utilize reim-
ported drugs in their prescription
plans.
The Food and Drug
Administration and opponents of
reimportation counter that this legisla-
tion would endanger the drug supply.
During an "import blitz" this summer,
the FDA and U.S. Customs examined
packages expected to contain pre-
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scription drugs from foreign coun-
tries, 16% of which were Canadian.
While many packages appeared to
contain FDA-approved drugs, 88%
violated some FDA provision. For
instance, the drugs were different than
those approved in the United States,
had inadequate labeling, had been
removed from the market, or were
inadequately packaged.7
The Illinois Policy Institute
has raised concerns that terrorists
might take advantage of weaknesses
in the supply chain to taint the drug
supply. As the import blitz illustrated,
U.S. Customs and the FDA do not
have the manpower to examine all the
drugs coming into the country; the
burden of ensuring a safe drug supply
would be enormous.8 Moreover, free-
market experts predict that pharma-
ceutical companies may stop selling
large quantities overseas, limiting the
amount of drugs that could be reim-
ported, and that reduced revenue from
American consumers could stunt
research and development.
Emanuel disagrees, claiming
that the passage of the bill would cre-
ate the kind of competition that would
balance out prices worldwide.
Additionally, the bill would actually
improve the safety of imported drugs
through the use of inexpensive coun-
terfeit-resistant technology. Finally,
because the pharmaceutical industry
receives so many tax breaks, taxpay-
ers already generate sufficient rev-
enue to maintain research and devel-
opment, he said.
While reimportation is gener-
ally seen only as a short-term solution
to rising drug costs, Emanuel believes
that even if a prescription-drug bene-
fit is passed this year, seniors will still
be left with significant out-of-pocket
costs. The cost-savings of reimported
drugs could help, and the support
from seniors is evident.
"We have received calls and
letters from seniors around this coun-
try thanking us for fighting for this
issue," Emanuel said.
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The Supreme Court is bal-
ancing the rights of employers to
create company policy against an
individual's right to work. On
October 8, 2003, the Court heard
oral arguments in Raytheon v.
Hernandez to resolve whether a
record of past drug abuse qualifies
for protection under the American
with Disabilities Act ("ADA").'
Raytheon seeks to protect the
integrity of its company policy
while Joel Hernandez claims
Raytheon's policy discriminated
against him as a prior drug abuser.
In 1991, Hernandez was
given a drug test at his place of
employment and tested positive for
cocaine. 2 At the time of the test, he
worked on government defense
missiles as a Calibration Service
Technician for Hughes Missile
Systems Company ("Hughes"), a
government defense contractor and
subsidiary of Raytheon Company.
Hernandez also had prior alcohol
problems coupled with excessive
absenteeism. In light of the positive
cocaine test, Hernandez exercised
an option to resign in lieu of termi-
nation.
Over two years later in
January 1994, Hernandez applied
for rehire by Hughes as a Product
Test Specialist, a position in which
Hernandez had prior experience.
Hernandez supplied Hughes with
two letters of recommendation: one
from his pastor and the other from
his sponsor in Alcoholics
Anonymous, which stated
Hernandez's progress in substance
recovery. Hughes rejected the appli-
cation after its Labor Relations
Department found that his
Employee Separation Summary
reflected that Hernandez resigned
in lieu of termination due to prior
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